Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Peritoneal dialysis (PD) is a modality of renal replacement therapy. Its effectiveness depends on the proper monitoring of clinical and laboratory parameters, as well as the control of infectious and cardiovascular complications. The establishment and evaluation of international targets, such as rates of peritonitis, exitsite infections, hospitalizations, and mortality, allow for the assessment of the quality of care and health outcomes in this population. Peritonitis is one of the main complications associated with PD and can lead to treatment failure, transfer to hemodialysis, or even death, making it one of the primary quality indicators.
A 5-year descriptive observational study was conducted at a peritoneal dialysis center in Guadalajara, Mexico. The entire population enrolled in the peritoneal dialysis program and under follow up was included. Fourteen targets derived from various international consensus statements and guidelines established for PD patient populations were recorded, with the aim of presenting our center’s experience in terms of quality of care.
Data from the years 2017, 2018, 2019, 2023, and 2024 were analyzed. We did not have records for 2020, 2021, and 2022 due to the COVID-19 pandemic. In recent years, the average mortality was 8% and hospitalization was less than 0.8 patients per month, with an average of 0.5 patient hospitalization days per month post pandemic, meeting international targets. Regarding peritonitis goals, during this period there were 0.17 episodes of peritonitis per patient year, with a 4.2% transfer rate to hemodialysis; however, cultures were negative in more than 20% of cases. Hemoglobin (Hb) and erythropoietin (EPO) dosing targets were met intermittently; however, blood pressure targets have not yet been achieved in patients.
Over the years, our center has met the most relevant targets for patients on peritoneal dialysis, such as mortality, hospitalization, peritonitis, and transfer to hemodialysis. This is a result of the standardized protocol of continuous training for patients and caregivers, as well as the availability of immediate care for any eventuality, both by phone and in person.
